ROBERT J. LEFKOWITZ MD - 21 May 2023 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
Director
Signature
/s/ Robert J. Lefkowitz
Issuer symbol
LXRX
Transactions as of
21 May 2023
Net transactions value
$0
Form type
4
Filing time
22 May 2023, 16:04:39 UTC
Previous filing
28 Apr 2023
Next filing
29 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise $0 +9,302 +30% $0.000000 40,332 21 May 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise $0 -9,302 -100% $0.000000* 0 21 May 2023 Common Stock 9,302 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock.